208 related articles for article (PubMed ID: 10349860)
1. A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue.
Sato N; Hori O; Yamaguchi A; Lambert JC; Chartier-Harlin MC; Robinson PA; Delacourte A; Schmidt AM; Furuyama T; Imaizumi K; Tohyama M; Takagi T
J Neurochem; 1999 Jun; 72(6):2498-505. PubMed ID: 10349860
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of the presenilin 1 (S182) gene in "sporadic" cases of Alzheimer's disease: identification and characterisation of unusual splice variants.
Anwar R; Moynihan TP; Ardley H; Brindle N; Coletta PL; Cairns N; Markham AF; Robinson PA
J Neurochem; 1996 Apr; 66(4):1774-7. PubMed ID: 8627338
[TBL] [Abstract][Full Text] [Related]
3. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease.
Mattila KM; Forsell C; Pirttilä T; Rinne JO; Lehtimäki T; Röyttä M; Lilius L; Eerola A; St George-Hyslop PH; Frey H; Lannfelt L
Ann Neurol; 1998 Dec; 44(6):965-7. PubMed ID: 9851443
[TBL] [Abstract][Full Text] [Related]
4. Expression of truncated presenilin 2 splice variant in Alzheimer's disease, bipolar disorder, and schizophrenia brain cortex.
Smith MJ; Sharples RA; Evin G; McLean CA; Dean B; Pavey G; Fantino E; Cotton RG; Imaizumi K; Masters CL; Cappai R; Culvenor JG
Brain Res Mol Brain Res; 2004 Aug; 127(1-2):128-35. PubMed ID: 15306129
[TBL] [Abstract][Full Text] [Related]
5. Structure and alternative splicing of the presenilin-2 gene.
Prihar G; Fuldner RA; Perez-Tur J; Lincoln S; Duff K; Crook R; Hardy J; Philips CA; Venter C; Talbot C; Clark RF; Goate A; Li J; Potter H; Karran E; Roberts GW; Hutton M; Adams MD
Neuroreport; 1996 Jul; 7(10):1680-4. PubMed ID: 8904781
[TBL] [Abstract][Full Text] [Related]
6. Alteration in brain presenilin-1 mRNA expression in sporadic Alzheimer's disease.
Isoe-Wada K; Urakami K; Wakutani Y; Adachi Y; Arai H; Sasaki H; Nakashima K
Eur J Neurol; 1999 Mar; 6(2):163-7. PubMed ID: 10053228
[TBL] [Abstract][Full Text] [Related]
7. Induced HMGA1a expression causes aberrant splicing of Presenilin-2 pre-mRNA in sporadic Alzheimer's disease.
Manabe T; Katayama T; Sato N; Gomi F; Hitomi J; Yanagita T; Kudo T; Honda A; Mori Y; Matsuzaki S; Imaizumi K; Mayeda A; Tohyama M
Cell Death Differ; 2003 Jun; 10(6):698-708. PubMed ID: 12761578
[TBL] [Abstract][Full Text] [Related]
8. Prominent expression of presenilin-1 in senile plaques and reactive astrocytes in Alzheimer's disease brain.
Weggen S; Diehlmann A; Buslei R; Beyreuther K; Bayer TA
Neuroreport; 1998 Oct; 9(14):3279-83. PubMed ID: 9831464
[TBL] [Abstract][Full Text] [Related]
9. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene.
Perez-Tur J; Froelich S; Prihar G; Crook R; Baker M; Duff K; Wragg M; Busfield F; Lendon C; Clark RF
Neuroreport; 1995 Dec; 7(1):297-301. PubMed ID: 8742474
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of Alzheimer's disease.
Goate AM
Geriatrics; 1997 Sep; 52 Suppl 2():S9-12. PubMed ID: 9307578
[TBL] [Abstract][Full Text] [Related]
11. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families.
Alzheimer's Disease Collaborative Group
Nat Genet; 1995 Oct; 11(2):219-22. PubMed ID: 7550356
[TBL] [Abstract][Full Text] [Related]
12. Familial Alzheimer's disease genes in Japanese.
Kamimura K; Tanahashi H; Yamanaka H; Takahashi K; Asada T; Tabira T
J Neurol Sci; 1998 Sep; 160(1):76-81. PubMed ID: 9804121
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutation analysis of the APP and Presenilin 1 and 2 genes in Alzheimer's disease brains.
Reznik-Wolf H; Machado J; Haroutunian V; DeMarco L; Walter GF; Goldman B; Davidson M; Johnston JA; Lannfelt L; Dani SU; Friedman E
J Neurogenet; 1998 Jan; 12(1):55-65. PubMed ID: 9666901
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in the predicted TM2 domain of the presenilin 2 gene in a Spanish patient with late-onset Alzheimer's disease.
Lao JI; Beyer K; Fernández-Novoa L; Cacabelos R
Neurogenetics; 1998 Aug; 1(4):293-6. PubMed ID: 10732806
[TBL] [Abstract][Full Text] [Related]
15. ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families.
Houlden H; Crook R; Backhovens H; Prihar G; Baker M; Hutton M; Rossor M; Martin JJ; Van Broeckhoven C; Hardy J
Am J Med Genet; 1998 Feb; 81(1):117-21. PubMed ID: 9514597
[TBL] [Abstract][Full Text] [Related]
16. Identification of regulatory cis-acting elements for alternative splicing of presenilin 2 exon 5 under hypoxic stress conditions.
Higashide S; Morikawa K; Okumura M; Kondo S; Ogata M; Murakami T; Yamashita A; Kanemoto S; Manabe T; Imaizumi K
J Neurochem; 2004 Dec; 91(5):1191-8. PubMed ID: 15569262
[TBL] [Abstract][Full Text] [Related]
17. Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia.
Matsushita S; Arai H; Muramatsu T; Makimoto K; Nakagawa T; Sasaki H; Higuchi S
Exp Neurol; 1997 Aug; 146(2):567-9. PubMed ID: 9270069
[TBL] [Abstract][Full Text] [Related]
18. Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy.
Kwok JB; Halliday GM; Brooks WS; Dolios G; Laudon H; Murayama O; Hallupp M; Badenhop RF; Vickers J; Wang R; Naslund J; Takashima A; Gandy SE; Schofield PR
J Biol Chem; 2003 Feb; 278(9):6748-54. PubMed ID: 12493737
[TBL] [Abstract][Full Text] [Related]
19. [Genetic factors and a polygenic model of Alzheimer's disease].
Rogaev EI
Genetika; 1999 Nov; 35(11):1558-71. PubMed ID: 10624576
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant.
Sherrington R; Froelich S; Sorbi S; Campion D; Chi H; Rogaeva EA; Levesque G; Rogaev EI; Lin C; Liang Y; Ikeda M; Mar L; Brice A; Agid Y; Percy ME; Clerget-Darpoux F; Piacentini S; Marcon G; Nacmias B; Amaducci L; Frebourg T; Lannfelt L; Rommens JM; St George-Hyslop PH
Hum Mol Genet; 1996 Jul; 5(7):985-8. PubMed ID: 8817335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
